EAMC reduces number of first-dose vaccine appointments
https://www.wtvm.com/2021/02/22/eamc-reduces-number-first-dose-vaccine-appointments/
OPELIKA, Ala. (WTVM) - Thousands of people have received their first dose of Pfizer’s COVID-19 vaccine in the past three weeks at the East Alabama Medical Center’s (EAMC) community vaccine clinic.
Now, officials say it is time for many to receive their second shot.
Sonya Mocks received her first dose at the community vaccine clinic last week.
“There were people there, but it worked like clockwork,” she said. “It was a great experience, considering I was there for a vaccination.”
She is now scheduled to get that second dose in a few weeks.
“I’m not as apprehensive about it as I was in the beginning,” Mocks said.
According to EAMC, to accommodate the number of people like Mocks who need their second COVID-19 shot, about 800 of the roughly 1,200 doses EAMC administers daily will go to those receiving a second dose.
“I think about two-thirds will be second doses,” said John Atkinson, EAMC’s PR and marketing director. “So, that does leave about a one-third of shots available for people trying to get their first dose still.”
According to hospital leaders, on March 15, the pattern will switch.
“It’ll be just the other way around,” Atkinson said. “[In three weeks] we’ll have 800 new first doses to be available and only 400 second doses.”
When it comes to long-term plans, officials with EAMC said they plan to keep the clinic open until at least the end of April.
“We’ll just have to evaluate it each month and see how it goes and see if there’s more vaccine in the community by then,” Atkinson said.
Having the clinic open longer is something Mocks said is a good thing.
“As we see more and more people getting vaccinated, then it gives people the courage to say okay, ‘I’m going to go ahead and do it,’” Mocks said. “And when the process is as simple as what I went through, then you don’t mind.”
Copyright 2021 WTVM. All rights reserved.
INDIANAPOLIS, Feb. 8, 2021 /PRNewswire/ -- eCoronaPass has announced a partnership with East Alabama Medical Center (EAMC) in providing a vaccination management software solution. The software features the ability for self-scheduling of vaccines, real-time reporting, inventory management, and much more.
eCoronaPass was able to meet the deadline of less than 2 weeks to have the software set up, allowing for Alabama residents to sign up and schedule their COVID vaccine. The software is fully scalable and functional to meet the demands of EAMC, capable of handling over 1 million people simultaneously.
Through this partnership, eCoronaPass will facilitate and expand its ease-of-use software into other counties in the state of Alabama. The software features compliance with the state, as well as offering real-time reporting.
"We are excited for this new partnership with EAMC," says Happy Dhani, CEO of Softbir, the leader of medical software solutions which includes eCoronaPass. "Our eCoronaPass software has been an effective platform for healthcare providers. We knew that optimizing our software to be able to incorporate effective modules for the vaccination rollout was necessary for successful implementation. It is more critical than ever to rapidly deploy these vaccines with ease of use to healthcare providers and suppliers."
The United States has overall struggled with the vaccine rollout regarding organization, inventory tracking, scheduling, and more. eCoronaPass is helping EAMC overcome these obstacles to efficiently distribute vaccines to Alabama residents, saving lives and creating a healthier atmosphere for the state.
The inventory management feature of the software will allow for EAMC to keep tracking of vaccines being administered to patients, as well as being able to track the total vaccines stored in order to prevent waste since that has become a major problem in the country's rollout.
The eCoronaPass software will give EAMC and its patients a peace-of-mind. Patients can take control of their health by scheduling appointments with available EAMC sites that fit their availability and needs.
eCoronaPass is built on Amazon Web Services (AWS), compliant with HIPAA/HITECH/NIST standards, and follows all FDA/CDC regulations, allowing for a safe and secure portal for patients and providers.
Learn more about eCoronaPass in this video.
Media Contact
Jim Ray Rodriguez
317-561-9125
jimray@softbir.com
https://ecoronapass.com/vaccine-management/
eCoronaPass Launches Optimized Software Platform to Facilitate COVID-19 Tests and Vaccinations Nationwide
eCoronaPass will assist schools, governments (county, state, federal), private companies, healthcare workers, and more in coordinating the vaccination efforts with a comprehensive software platform that will help mitigate COVID-19 risks, vaccination waste reduction, and automated data reporting for CDC and state requirements.
INDIANAPOLIS, Jan. 11, 2021 /PRNewswire/ -- Vaccines for the COVID-19 virus have begun to roll out across the United States, and eCoronaPass is helping lead the charge with its new software platform that effectively manages vaccination scheduling, symptom tracking, and data reporting that is needed by government entities, health systems, and private employers.
The rollout of the coronavirus vaccine has already experienced some struggles with states scrambling to distribute the available COVID-19 vaccines. Softbir has created eCoronaPass to redesign how these vaccines should be properly managed and distributed. Softbir believes its platform is the answer and solution to all these complicated issues.
"Our eCoronaPass software has been an effective platform for healthcare providers offering COVID testing services since the beginning of the pandemic. We knew that optimizing our software to be able to incorporate effective modules for the vaccination rollout was necessary for successful implementation. It is more critical than ever to rapidly deploy these vaccines with ease of use to healthcare providers and suppliers."
Safe, Reliable, Fast & Easy-to-Use Software
The platform is built and supported through Amazon Web Services (AWS), making it the most reliable and easily accessible cloud platform for any client to use.
eCoronaPass is also compliant with HIPAA, HITECH, and NIST standards, and follows all FDA/CDC regulations, allowing for a safe and secure portal for patients and providers.
Proactive Deployment Monitoring of Vaccines
eCoronaPass will save lives by effectively managing and proactively monitoring the implementation of the vaccines. Deployment of vaccines will be faster, more agile, and easier than ever, allowing for scheduling of COVID-19 testing services and vaccinations.
Patients can take control of their health by scheduling appointments with approved sites that fit their availability and needs. The locator module allows for patients to find areas nearest to them to get vaccinated as quickly as possible.
Effectiveness and Symptom Tracking
With its comprehensive COVID-19 test tracking and automated vaccine reporting, eCoronaPass will give patients peace-of-mind.
They will be able to self-monitor adverse vaccine reactions with data transferred automatically to the CDC directly via the Vaccine Adverse Event Reporting System (VAERS).
The effectiveness and symptoms tracking feature between the multiple available COVID-19 vaccines provide data for informed decision-making, ultimately improving population health.
Real-Time Adverse Effects Data
eCoronaPass includes administrative prioritization selection technology, with features including effective patient health-risk stratification and predictive care modules. One can pinpoint and select which populations will be segmented into different phases of vaccination programs. The platform is also powered to expand any contraindications as they are determined.
The platform displays a dashboard of real-time data regarding a population's health status, enabling a proactive reaction to the adverse effects of all available COVID-19 vaccines.
If you would like to learn more click HERE for a short explanation video.
Media Contact
Jim Ray Rodriguez
317-561-9125
SOURCE Softbir
Latest News from the CDC
- Long COVID BasicsLearn about the potential COVID-19 long-term effects, including fatigue, shortness of breath, brain fog, chest pain, headache, and other symptoms.
- Living with Long COVIDPeople with post-COVID conditions and those who support them can find ways to help, ways to cope with stress, and additional resources and support groups.
- COVID-19 Testing: What You Need to KnowLearn about testing for COVID-19, including the types of tests, who should get tested, how to get tested, and print resources in English and Spanish.
- COVID-19 Vaccines for People Who Are Moderately or Severely ImmunocompromisedLearn CDC recommendations for COVID-19 vaccines for moderately to severely immunocompromised people. An additional dose is recommended.
- COVID-19 Vaccine EffectivenessCOVID-19 vaccines authorized for use in the U.S. are working well based on studies that have looked at how vaccines work in real-world conditions.
- Overview of COVID-19 VaccinesFind an overview of the different COVID-19 vaccines available in the United States, including safety information and the ingredients of each vaccine.
- Allergic Reactions after COVID-19 VaccinationIf you get a COVID-19 vaccine and think you might be having a severe allergic reaction (anaphylaxis), seek immediate medical care by calling 911.
- COVID-19 Vaccine Safety in Children and TeensRead about the clinical trials, research, and ongoing safety monitoring that has shown that the COVID-19 vaccination is safe for children and teens.
- Data & SurveillanceFind COVID-19 data and surveillance, including the COVID Data Tracker, hospitalization data, serology surveillance, forecasting, and variant surveillance.
- Bust Myths and Learn the Facts about COVID-19 VaccinesLearn the facts about the authorized COVID-19 vaccines and bust common myths. CDC recommends eligible people age 5 and older get vaccinated.